In The Spotlight
Radiant14 has brought the conversation around young-onset colorectal cancer to national media, from the symptoms I initially ignored to the realities of recurrence, treatment, clinical trials, and fatherhood.
As Featured In
For Editors & Producers
About Joe
Joe Faratzis is the creator of Radiant14, a personal platform documenting life with Stage IV colorectal cancer. Diagnosed at 29 with Stage IIA rectal cancer, he later faced metastatic disease in his liver and lungs. Through Radiant14 and @radiant14percent, Joe shares first-person accounts of treatment, recurrence, clinical trials, fatherhood, symptoms, screening, and self-advocacy. He is currently participating in the BOT/BAL clinical trial.
Media Contact
For interviews, appearances, and media inquiries, contact Joe directly.
Featured Articles
Coverage of my symptoms, treatment, recurrence, and the decisions that come with living through Stage IV disease.
Inside Edition
February 2026
Inside Edition Feature
Joe shared his perspective on the passing of actor James Van Der Beek and the importance of colorectal cancer awareness for younger adults.
Newsweek
January 2026
I Have Stage 4 Colorectal Cancer. Now I Face an Impossible Decision
Joe shares the deeply personal decisions that come with recurrent disease, including how treatment choices intersect with fatherhood and quality of life.
New York Post
December 2024
Stage 4 Colorectal Cancer at 29: I Wish I Hadn't Ignored These Symptoms
Five years after an initial Stage IIA rectal cancer diagnosis that later became Stage IV, Joe Faratzis reflects on the six red flags that signaled a serious disease.
Read Full ArticleYahoo Lifestyle
December 2024
What It's Really Like with Stage 4 Cancer
Yahoo Lifestyle shares Joe's story of being diagnosed with rectal cancer at 29 and later facing metastatic disease, emphasizing the warning signs he wishes he had recognized earlier.
Read Full ArticleSELF
March 2024
How Joe Overcame Colorectal Cancer at 34
This SELF article highlights Joe's journey confronting colorectal cancer at a young age, showcasing his resilience, treatment strategies, and outlook on life.
Read Full ArticleTimes Now News
March 2024
Colorectal Cancer Symptoms: The Pain Ignored for Months
This Times Now News article details how Joe overlooked subtle but persistent symptoms for months before his colorectal cancer diagnosis, underlining the need for vigilance and timely medical attention.
Read Full ArticleSELF
December 2024
Self-Care With a Chronic Condition
In this SELF feature, Joe's journey illustrates approaches to maintaining mental and physical well-being when living with a chronic condition or recovering from serious illness.
Read Full ArticleSurvivorNet
March 2024
From Hemorrhoids to a Colon Cancer Diagnosis
SurvivorNet covers Joe's story about initially attributing rectal bleeding to hemorrhoids, only to discover it was a sign of rectal cancer, emphasizing the importance of seeking prompt medical evaluation.
Read Full ArticleLADbible
December 2024
Man with Incurable Colon Cancer Ignored Symptoms
LADbible highlights Joe's experience with metastatic colorectal cancer, underscoring the symptoms he ignored and the lessons learned.
Read Full ArticleTimes Now News
December 2024
Symptoms of Colon Cancer to Never Ignore
Times Now News lists six colon cancer symptoms Joe wished he had paid attention to, offering valuable advice for others.
Read Full ArticleNewsbreak
December 2024
Stage 4 Colon Cancer: Symptoms Ignored
Newsbreak covers Joe's reflections on the symptoms he ignored before his initial rectal cancer diagnosis and what he wants others to learn from his journey.
Read Full ArticleMedical Daily
December 2024
Night Sweats and Bowel Changes: Cancer Survivor Reflects
Medical Daily examines Joe's reflections on the red flags he overlooked, including night sweats and bowel habit changes, as signs of colorectal cancer.
Read Full ArticleWant to Feature My Story?
I'm available to discuss young-onset colorectal cancer, symptoms, recurrence, treatment, clinical trials, patient self-advocacy, and fatherhood during Stage IV disease.